Ketorolac (Toradol) for Acute Pain Control After a Personal Injury

James Wong — Founder & Pharmacist, LienScripts | December 26, 2024 | 6 min read

Ketorolac (Toradol) is a potent non-opioid NSAID used for short-term acute pain management. In personal injury cases, it bridges the period between initial injury and establishment of longer-term pain management without introducing opioid risk. Understanding when it's prescribed and how it fits into the medication record matters for PI attorneys and patients.

[!KEY] Ketorolac (Toradol) is the most potent non-opioid NSAID available and provides opioid-comparable acute analgesia — its prescription signals that the treating physician assessed pain as severe enough to warrant potent non-opioid intervention, and its 5-day FDA-approved maximum oral course makes it a well-defined bridging agent between emergency care and long-term outpatient pain management.

What Is Ketorolac?

Ketorolac (brand name Toradol) is a nonsteroidal anti-inflammatory drug (NSAID) notable for its unusually high analgesic potency. Unlike other NSAIDs, which are primarily used for mild to moderate pain and inflammation, ketorolac provides analgesia comparable to moderate-dose opioids for many types of acute pain — without opioid side effects or addiction risk.

Because of its potency and GI/renal risk profile with extended use, ketorolac is FDA-approved for short-term use only: typically 5 days maximum for oral administration, shorter for injectable forms. This makes it a bridging agent — powerful acute pain control for a defined period — rather than a long-term treatment.

In personal injury cases, ketorolac is most commonly used in two contexts: as injectable pain management in the emergency department or urgent care setting immediately after injury, and as short-course oral treatment in the immediate post-acute phase before longer-term pain management is established.

Why Physicians Prescribe Ketorolac After Injuries

The clinical rationale for ketorolac in PI cases is the need for potent non-opioid pain control in the acute phase. For patients where the treating physician wants to avoid opioids (history of substance use, respiratory concerns, patient preference) but the pain level genuinely requires more than a standard NSAID, ketorolac fills the gap.

Common injury presentations that may prompt ketorolac prescribing include:

• Severe soft tissue injury with significant acute inflammatory pain
• Post-fracture pain management in patients who cannot receive opioids
• Severe cervical or lumbar muscle spasm with significant inflammatory component
• Post-reduction pain after joint dislocation
• Transition from emergency department care where IV/IM ketorolac was used

The short treatment course means ketorolac is almost always part of a multi-medication strategy, not a standalone treatment.

Ketorolac in the Emergency and Urgent Care Setting

Emergency physicians and urgent care providers frequently administer intramuscular (IM) ketorolac for acute pain management in PI patients. The IM form provides rapid, potent analgesia without the sedation or opioid risks of morphine or hydromorphone — which is why many emergency providers prefer it for acute musculoskeletal pain management.

When a patient transitions from emergency or urgent care to outpatient treatment, a short course of oral ketorolac may bridge the gap between the EM visit and the establishment of ongoing outpatient pain management with the treating physician. This transition prescription is often the entry point for pharmacy lien coverage — the first outpatient prescription that should be filled under the lien.

The Medication Record Value of Ketorolac Prescribing

In PI cases, a ketorolac prescription creates a specific clinical signal: the treating physician assessed the patient's pain as severe enough to warrant a potent non-opioid analgesic. This is medically significant documentation.

For cases where the patient is reporting severe acute pain and the defense is challenging the severity of the reported injury, a ketorolac prescription is objective evidence of a licensed physician's clinical assessment that the pain level required a potent analgesic agent. The prescribing decision is documented, date-stamped, and part of the medical record.

GI Protection with Ketorolac

[!NOTE] A proton pump inhibitor co-prescribed with ketorolac — such as omeprazole or pantoprazole — is clinically appropriate given ketorolac's potency, and its presence in the pharmacy record further demonstrates a physician managing the full clinical picture of the patient's care rather than prescribing in isolation.

All NSAIDs carry GI risk, and ketorolac's potency means this risk is present even with the short approved treatment course. Physicians often co-prescribe a proton pump inhibitor (omeprazole, pantoprazole) when prescribing ketorolac, particularly for patients who will be simultaneously taking other NSAIDs or who have GI risk factors.

The PPI co-prescription is medically appropriate and creates an additional entry in the pharmacy record that is consistent with a physician managing the full clinical picture of the patient's care — not just prescribing individually, but managing the regimen as a whole.

Coverage Under a Pharmacy Lien

Oral ketorolac prescribed for acute injury-related pain is covered under a LienScripts pharmacy lien. The dispensing record creates a documented acute pain management event in the medication timeline.

For patients transitioning from emergency or urgent care to outpatient treatment who have been prescribed short-course ketorolac, ensuring that prescription is filled under the pharmacy lien establishes the medication record from day one of outpatient treatment.

[!KEY] Ketorolac's FDA-mandated 5-day maximum oral course means the prescription is inherently self-limiting — the defense cannot credibly argue over-prescribing, making it clean, defensible documentation of severe acute pain at the outset of treatment.

[!KEY] A ketorolac prescription filled under the pharmacy lien on day one of outpatient care anchors the medication timeline to the earliest possible post-injury date — establishing causation and injury onset through an independent pharmacy record from the moment treatment began.

For more information about pharmacy lien coverage, visit for patients or how it works.

Related Resources

• Pharmacy Services for Personal Injury Clients: How It Works
• What Are Medication Liens?